A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer

NCT06395753 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Debio 4228

Sponsor

Debiopharm International SA